Michael Shetzline
2021
In 2021, Michael Shetzline earned a total compensation of $2.6M as Senior Vice President, Chief Medical Officer, and Head of Research and Drug Development at Ironwood Pharmaceuticals, a 39% increase compared to previous year.
Compensation breakdown
| Bonus | $121,000 |
|---|---|
| Non-Equity Incentive Plan | $285,405 |
| Salary | $483,447 |
| Stock Awards | $1,727,931 |
| Other | $18,090 |
| Total | $2,635,873 |
Shetzline received $1.7M in stock awards, accounting for 66% of the total pay in 2021.
Shetzline also received $121K in bonus, $285.4K in non-equity incentive plan, $483.4K in salary and $18.1K in other compensation.
Rankings
In 2021, Michael Shetzline's compensation ranked 4,940th out of 12,415 executives tracked by ExecPay. In other words, Shetzline earned more than 60.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,940 out of 12,415 | 60th |
Division Manufacturing | 2,070 out of 5,505 | 62nd |
Major group Chemicals And Allied Products | 880 out of 2,375 | 63rd |
Industry group Drugs | 787 out of 2,096 | 63rd |
Industry Pharmaceutical Preparations | 561 out of 1,546 | 64th |
Source: SEC filing on April 21, 2022.
Shetzline's colleagues
We found six more compensation records of executives who worked with Michael Shetzline at Ironwood Pharmaceuticals in 2021.
2021
Thomas McCourt
Ironwood Pharmaceuticals
Chief Executive Officer
2021
Jason Rickard
Ironwood Pharmaceuticals
Chief Operating Officer
2021
John Minardo
Ironwood Pharmaceuticals
Chief Legal Officer
2021
Gina Consylman
Ironwood Pharmaceuticals
Chief Financial Officer
2021
Sravan Emany
Ironwood Pharmaceuticals
Chief Financial Officer
2021
Mark Mallon
Ironwood Pharmaceuticals